These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Use of Acular LS in the pain management of keratoconus: a pilot study. Yu JO; Gundel RE Optom Vis Sci; 2010 Feb; 87(2):125-30. PubMed ID: 19996813 [TBL] [Abstract][Full Text] [Related]
33. Use of intranasal ketorolac and modified oral aspirin challenge for desensitization of aspirin-exacerbated respiratory disease. Lee RU; White AA; Ding D; Dursun AB; Woessner KM; Simon RA; Stevenson DD Ann Allergy Asthma Immunol; 2010 Aug; 105(2):130-5. PubMed ID: 20674823 [TBL] [Abstract][Full Text] [Related]
34. Bleeding risk with ketorolac after lumbar microdiscectomy. Chin KR; Sundram H; Marcotte P J Spinal Disord Tech; 2007 Apr; 20(2):123-6. PubMed ID: 17414980 [TBL] [Abstract][Full Text] [Related]
35. Paracetamol and ketorolac pharmacokinetics and metabolism at delivery and during postpartum. Allegaert K; van Calsteren K; Hendrickx S; Kelchtermans J; Smits A; Kulo A; van de Velde M Acta Anaesthesiol Belg; 2012; 63(3):121-5. PubMed ID: 23397664 [TBL] [Abstract][Full Text] [Related]
36. Development and in vitro evaluations of gelatin A microspheres of ketorolac tromethamine for intranasal administration. Sankar C; Mishra B Acta Pharm; 2003 Jun; 53(2):101-10. PubMed ID: 14764244 [TBL] [Abstract][Full Text] [Related]
37. Postoperative ketorolac tromethamine use in infants aged 6-18 months: the effect on morphine usage, safety assessment, and stereo-specific pharmacokinetics. Lynn AM; Bradford H; Kantor ED; Seng KY; Salinger DH; Chen J; Ellenbogen RG; Vicini P; Anderson GD Anesth Analg; 2007 May; 104(5):1040-51, tables of contents. PubMed ID: 17456651 [TBL] [Abstract][Full Text] [Related]
38. Effect of preservative, antioxidant and viscolizing agents on in vitro transcorneal permeation of ketorolac tromethamine. Malhotra M; Majumdar DK Indian J Exp Biol; 2002 May; 40(5):555-9. PubMed ID: 12622201 [TBL] [Abstract][Full Text] [Related]
39. Formulation and pharmacokinetics of ketorolac tromethamine fast dissolving tablets. Mettu SR; Veerareddy PR Drug Res (Stuttg); 2013 Nov; 63(11):586-90. PubMed ID: 23780501 [TBL] [Abstract][Full Text] [Related]
40. Ketorolac tromethamine pharmacokinetics and metabolism after intravenous, intramuscular, and oral administration in humans and animals. Mroszczak EJ; Jung D; Yee J; Bynum L; Sevelius H; Massey I Pharmacotherapy; 1990; 10(6 ( Pt 2)):33S-39S. PubMed ID: 2082311 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]